April 03, 2015Article
Reduced efficacy of sumatriptan in migraine with aura vs without aura
Jakob Møller Hansen, Peter J. Goadsby, Andrew Charles
First published April 3, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001535
Jakob Møller Hansen
From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR–Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Peter J. Goadsby
From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR–Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Andrew Charles
From the Headache Research and Treatment Program (J.M.H., A.C.), Department of Neurology, University of California Los Angeles; Headache Group (P.J.G.), Department of Neurology, University of California San Francisco; NIHR–Wellcome Trust Clinical Research Facility (P.J.G.), King's College, London, UK; and Danish Headache Centre and Department of Neurology (J.M.H.), Glostrup Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Chinese Translation
Neurology® data supplements are not copyedited before publication. Published editorials
and translations have been copyedited.
© 2017 American Academy of Neurology.
Files in this Data Supplement:
- Chinese Translation - PDF